Want to see DE:SRT3 full AI Analyst Report?
SRT3 Stock Chart & Stats
€238.80
€2.70(1.17%)
At close: 4:00 PM EST
€238.80
€2.70(1.17%)
Day’s Range― - ―
52-Week Range€175.95 - €267.70
Previous CloseN/A
Volume14.14K
Average Volume (3M)153.86K
Market Cap
€14.10B
Enterprise Value€19.48B
Total Cash (Recent Filing)€573.80M
Total Debt (Recent Filing)€4.30B
Price to Earnings (P/E)95.3
Beta1.55
Next Earnings
Jul 23, 2026EPS Estimate
1.36Next Dividend Ex-DateN/A
Dividend Yield0.3%
Share Statistics
EPS (TTM)2.35
Shares Outstanding37,440,000
10 Day Avg. Volume126,110
30 Day Avg. Volume153,863
Financial Highlights & Ratios
PEG Ratio1.32
Price to Book (P/B)6.31
Price to Sales (P/S)4.82
P/FCF Ratio79.72
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€267.18Price Target Upside11.89% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
EPS Forecast (FY)5.39
Revenue Forecast (FY)€3.74B
Bulls Say, Bears Say
Bulls Say
Earnings PerformanceSartorius AG delivered a 7% beat on EBITDA compared to consensus, which is considered a positive result.
Growth ExpectationsThe guidance for EBITDA was raised to 30% at the high point, indicating strong performance expectations.
Bears Say
Product Segment PerformanceLab products and services showed weakness with a decline in revenue and missed EBITDA estimates, highlighting concerns in equipment purchasing.
Sartorius News
SRT3 FAQ
What was Sartorius AG’s price range in the past 12 months?
Sartorius AG lowest stock price was €175.95 and its highest was €267.70 in the past 12 months.
What is Sartorius AG’s market cap?
Sartorius AG’s market cap is €14.10B.
When is Sartorius AG’s upcoming earnings report date?
Sartorius AG’s upcoming earnings report date is Jul 23, 2026 which is in 24 days.
How were Sartorius AG’s earnings last quarter?
Sartorius AG released its earnings results on Apr 23, 2026. The company reported €1.2 earnings per share for the quarter, missing the consensus estimate of €1.284 by -€0.084.
Is Sartorius AG overvalued?
According to Wall Street analysts Sartorius AG’s price is currently Undervalued.
Does Sartorius AG pay dividends?
Sartorius AG pays a Annually dividend of €0.74 which represents an annual dividend yield of 0.3%. See more information on Sartorius AG dividends here
What is Sartorius AG’s EPS estimate?
Sartorius AG’s EPS estimate is 1.36.
How many shares outstanding does Sartorius AG have?
Sartorius AG has 37,440,000 shares outstanding.
What happened to Sartorius AG’s price movement after its last earnings report?
Sartorius AG reported an EPS of €1.2 in its last earnings report, missing expectations of €1.284. Following the earnings report the stock price went down -9.018%.
Which hedge fund is a major shareholder of Sartorius AG?
Currently, no hedge funds are holding shares in DE:SRT3
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sartorius Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€267.18 (11.89% Upside)
€267.18 (11.89% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.35%
12-Months-Change
Fundamentals
Return on Equity
6.05%
Trailing 12-Months
Asset Growth
-2.38%
Trailing 12-Months
Company Description
Sartorius AG
Sartorius AG is a global supplier of advanced bioprocess and laboratory solutions, offering a comprehensive portfolio of products and services essential for life science research and biopharmaceutical manufacturing. The company's offerings include sophisticated biosensors and detection systems, live-cell analysis platforms, and a wide array of cell culture media and reagents. Sartorius also manufactures various bioreactors, ranging from benchtop to large-scale single-use and stainless steel systems, along with their associated software applications. Its extensive filtration product line encompasses membranes, specialized filters, and diverse devices for ultrafiltration, sterile filtration, and sample preparation. Furthermore, Sartorius provides process chromatography and fluid management solutions, industrial microbiology systems, water purification units, and essential lab equipment such as weighing, pipetting, and centrifugation systems. Beyond products, the company delivers critical services including bioprocess development, protein expression, and validation. Serving sectors like life science research, biopharmaceutical manufacturing, and quality control, Sartorius was established in 1870 and is headquartered in Göttingen, Germany.
SRT3 Stock 12 Month Forecast
Average Price Target
€267.18
▲(11.89% Upside)
Technical Analysis
Carl Zeiss Meditec
―
GEA Group AG
―
Gerresheimer
―
Pfeiffer Vacuum Technology
―
STRATEC Biomedical
―
Options Prices
Currently, No data available
---






